Provided by Tiger Trade Technology Pte. Ltd.

Pacira Pharmaceuticals

21.00
+0.64003.14%
Post-market: 21.000.00000.00%18:40 EST
Volume:746.54K
Turnover:15.58M
Market Cap:903.45M
PE:44.56
High:21.07
Open:20.61
Low:20.44
Close:20.36
52wk High:27.64
52wk Low:18.80
Shares:43.02M
Float Shares:37.84M
Volume Ratio:1.07
T/O Rate:1.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4713
EPS(LYR):-2.1529
ROE:2.90%
ROA:2.89%
PB:1.24
PE(LYR):-9.75

Loading ...

Pacira Biosciences Chief Administrative Officer Kristen Williams Reports Disposal of Common Shares

Reuters
·
Feb 04

Pacira Biosciences Files Initial Beneficial Ownership Statement for Director Samit Hirawat

Reuters
·
Jan 30

Pacira appoints Samit Hirawat to board of directors

TIPRANKS
·
Jan 28

Pacira Biosciences Appoints Samit Hirawat to Board of Directors

Reuters
·
Jan 28

Press Release: Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors

Dow Jones
·
Jan 28

Analysts Are Bullish on These Healthcare Stocks: Pacira Pharmaceuticals (PCRX), Inspire Medical Systems (INSP)

TIPRANKS
·
Jan 23

Pacira Biosciences Inc - to Receive Upfront Payment and Royalties From LG Chem

THOMSON REUTERS
·
Jan 13

Pacira Biosciences Inc - LG Chem Gains Exclusive Rights to Commercialize Exparel

THOMSON REUTERS
·
Jan 13

Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets

GlobeNewswire
·
Jan 13

Pacira BioSciences (PCRX) Is Down 6.3% After Cut 2025 Outlook And Activist Pressure - Has The Bull Case Changed?

Simply Wall St.
·
Jan 12

Assessing Pacira BioSciences (PCRX) Valuation After Record EXPAREL Quarter Buybacks And Activist Pressure

Simply Wall St.
·
Jan 10

Stock Track | Pacira Pharmaceuticals Plummets 13.37% Intraday After Reporting Preliminary FY25 Revenue Results

Stock Track
·
Jan 10

Crude Oil Rises Sharply; US Consumer Sentiment Edges Higher In January

Benzinga
·
Jan 10

Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Pacira Pharmaceuticals (PCRX) and Beta Bionics, Inc. (BBNX)

TIPRANKS
·
Jan 09

Pacira BioSciences Is Maintained at Buy by Needham

Dow Jones
·
Jan 09

Stocks to Watch: Cemtrex, Olin, Pacira BioSciences, Tilray Brands

Dow Jones
·
Jan 09

Pacira BioSciences Falls After Preliminary Sales Miss Estimates

Dow Jones
·
Jan 09

Pacira 2025 preliminary revenue slightly misses expectations

Reuters
·
Jan 09

Pacira Biosciences FY Revenue USD 726.4 Million VS. Ibes Estimate USD 737.8 Million

THOMSON REUTERS
·
Jan 09

Press Release: Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues

Dow Jones
·
Jan 09